Furthermore, both CCAT1 and PVT1 expression was found to be over 5 fold higher in t(8;21) positive versus t(8;21) negative AML samples and was associated with clinical parameter indicating higher risk and lower overall survival of AML patients positive for this translocation (124). The gene discussed is PVT1; the disease is acute myeloid leukemia.